Abstract
RBD has been proposed as an early marker of neurodegenerative diseases especially synucleinopathies, while less commonly an association has been reported between RBD and tauopathies. The RBD occurrence in disorders where there is substantial pathology in areas known to control motor aspects of REM sleep indicates that the site of neurological damage is more important that the molecular pathology. Moreover, there is a frequent overlap between synucleinopathies and tauopathies from the neuropathological standpoint. Considering together all the neurodegenerative encephalopathies, with the exception of Wilson’s disease, the most consistence feature seems that RBD associated with non-synuclein disorders occurs after the clinical disease is present, rather than before the onset of non-synuclein disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Friedman JH. Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3). Mov Disord. 2002;17:1350–3.
Iranzo A, Munoz E, Santamaria J, Vilaseca I, Mila M, Tolosa E. REM sleep behavior disorder and vocal cord paralysis in Machado-Joseph disease. Mov Disord. 2003;18:1179–83.
Chi NF, Shiao GM, Ku HL, Soong BW. Sleep disruption in spinocerebellar ataxia type 3: a genetic and polysomnographic study. J Chin Med Assoc. 2013;76(1):25–30. https://doi.org/10.1016/j.jcma.2012.09.006.
Pedroso JL, Braga-Neto P, Martinez AR, Martins CR Jr, Rezende Filho FM, Sobreira-Neto MA, Prado LB, do Prado GF, França MC Jr, Barsottini OG. Sleep disorders in Machado-Joseph disease. Curr Opin Psychiatry. 2016;29:402–8. https://doi.org/10.1097/YCO.0000000000000287.
Minz M, Autret A, Laff ont F, Beillevaire T, Cathala HP, Castaigne P. A study on sleep in amyotrophic lateral sclerosis. Biomedicine. 1979;30:40–6.
Sforza E, Krieger J, Petiau C. REM sleep behavior disorder: clinical and physiopathological findings. Sleep Med Rev. 1997;1:57–69.
Ebben MR, Shahbazi M, Lange DJ, Krieger AC. REM behavior disorder associated with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:473–4. https://doi.org/10.3109/17482968.2012.673172.
Puligheddu M, Congiu P, Aricò D, Rundo F, Borghero G, Marrosu F, Fantini ML, Ferri R. Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis. Sleep Med. 2016;26:16–22. https://doi.org/10.1016/j.sleep.2016.05.016.
Lo Coco D, Puligheddu M, Mattaliano P, Congiu P, Borghero G, Fantini ML, La Bella V, Ferri R. REM sleep behavior disorder and periodic leg movements during sleep in ALS. Acta Neurol Scand. 2017;135:219–24. https://doi.org/10.1111/ane.12593.
Tribl GG, Bor-Seng-Shu E, Trindade MC, Lucato LT, Teixeira MJ, Barbosa ER. Wilson’s disease presenting as rapid eye movement sleep behavior disorder: a possible window to early treatment. Arq Neuropsiquiatr. 2014;72:653–8.
Tribl GG, Trindade MC, Bittencourt T, Lorenzi-Filho G, Cardoso Alves R, Ciampi de Andrade D, Fonoff ET, Bor-Seng-Shu E, Machado AA, Schenck CH, Teixeira MJ, Barbosa ER. Wilson’s disease with and without rapid eye movement sleep behavior disorder compared to healthy matched controls. Sleep Med. 2016;17:179–85. https://doi.org/10.1016/j.sleep.2015.09.003.
Evans E, Mowat D, Wilson M, Einfeld S. Sleep disturbance in Mowat-Wilson syndrome. Am J Med Genet A. 2016;170(3):654–60. https://doi.org/10.1002/ajmg.a.37502.
Limongi JC. REM sleep behavior disorder, neurodegeneration and Wilson’s disease. Arq Neuropsiquiatr. 2014;72(9):649–50.
Nevsimalova S, Buskova J, Bruha R, Kemlink D, Sonka K, Vitek L, Marecek Z. Sleep disorders in Wilson’s disease. Eur J Neurol. 2011;18:184–90. https://doi.org/10.1111/j.1468-1331.2010.03106.x.
Arnulf I, Nielsen J, Lohmann E, Schiefer J, Wild E, Jennum P, Konofal E, Walker M, Oudiette D, Tabrizi S, Durr A. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol. 2008;65(4):482–8. https://doi.org/10.1001/archneur.65.4.482.
Piano C, Losurdo A, Della Marca G, Solito M, Calandra-Buonaura G, Provini F, Bentivoglio AR, Cortelli P. Polysomnographic findings and clinical correlates in Huntington disease: a cross-sectional cohort study. Sleep. 2015;38:1489–95. https://doi.org/10.5665/sleep.4996.
Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1–9.
Gross RA, Spehlmann R, Daniels JC. Sleep disturbances in progressive supranuclear palsy. Electroencephalogr Clin Neurophysiol. 1978;45:16–25.
Laffont F, Autret A, Minz M, Beillevaire T, Gilbert A, Cathala HP, Castaigne P. Polygraphic sleep recordings in 9 cases of Steele-Richardson’s disease. Rev Neurol (Paris). 1979;135:127–42.
Laffont F, Leger JM, Penicaud A, et al. Sleep abnormalities and evoked potentials (VEP-BAER-SEP) in progressive supranuclear palsy. Neurophysiol Clin. 1988;18:255–69.
Shimizu T, Inami Y, Sugita Y, Iijima S, Teshima Y, Matsuo R, Yasoshima A, Egawa I, Okawa M, Tashiro T, et al. REM sleep without muscle atonia (stage 1-REM) and its relation to delirious behavior during sleep in patients with degenerative diseases involving the brain stem. Jpn J Psychiatry Neurol. 1990;44:681–92.
Shimizu T, Sugita Y, Iijima S, Teshima Y, Hishikawa Y. Sleep study in patients with spinocerebellar degeneration and related diseases. In: Koella WP, editor. Sleep. Basel: S Karger; 1981. p. 435–7.
Pareja JA, Caminero AB, Masa JF, Dobato JL. A first case of progressive supranuclear palsy and pre- clinical REM sleep behavior disorder presenting as inhibition of speech during wakefulness and somniloquy with phasic muscle twitching during REM sleep. Neurologia. 1996;11:304–6.
Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123:331–9.
Arnulf I, Merino-Andreu M, Bloch F, Konofal E, Vidailhet M, Cochen V, Derenne JP, Agid Y. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep. 2005;28:349–54.
Sixel-Döring F, Schweitzer M, Mollenhauer B, Trenkwalder C. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Med. 2009;10:407–15. https://doi.org/10.1016/j.sleep.2008.05.004.
Warren NM, Piggott MA, Perry EK, Burn DJ. Cholinergic systems in progressive supranuclear palsy. Brain. 2005;128:239e49.
Mann DM, Yates PO, Hawkes J. The pathology of the human locus coeruleus. Clin Neuropathol. 1983;2:1e7.
Schenck CH, Garcia-Rill E, Skinner RD, Anderson ML, Mahowald MW. A case of REM sleep behavior disorder with autopsy-confirmed Alzheimer’s disease: postmortem brain stem histochemical analyses. Biol Psychiatry. 1996;40(5):422.
Schenck CH, Mahowald MW, Anderson ML, Silber MH, Boeve BF, Parisi JE. Lewy body variant of Alzheimer’s disease (AD) identified by postmortem ubiquitin staining in a previously reported case of AD associated with REM sleep behavior disorder. Biol Psychiatry. 1997;42:527–8.
Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder (RBD): 16-year update on a previously reported series. Sleep Med. 2013;14(8):744–8. https://doi.org/10.1016/j.sleep.2012.10.009.
Gagnon JF, Petit D, Fantini ML, Rompré S, Gauthier S, Panisset M, Robillard A, Montplaisir J. REM sleep behaviour disorder and REM sleep without atonia in Alzheimer’s disease. Sleep. 2006;29:1321–5.
Sinforiani E, Terzaghi E, Pasotti C, Zucchella C, Zambrelli E, Manni R. Hallucinations and sleep-wake cycle disturbances in Alzheimer’s disease: a questionnaire based study in 218 patients. Neurol Sci. 2007;28:96–9.
Wang P, Wing YK, Xing J, Liu Y, Zhou B, Zhang Z, Yao H, Guo Y, Shang Y, Zhang X. Rapid eye movement sleep behavior disorder in patients with probable Alzheimer's disease. Aging Clin Exp Res. 2016;28(5):951–7. https://doi.org/10.1007/s40520-015-0382-8.
Kim HJ, Im HK, Kim J, Han JY, de Leon M, Deshpande A, Moon WJ. Brain atrophy of secondary REM-sleep behavior disorder in neurodegenerative disease. J Alzheimers Dis. 2016;52:1101–9. https://doi.org/10.3233/JAD-151197.
Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197–204.
Noguchi-Shinohara M, Tokuda T, Yoshita M, Kasai T, Ono K, Nakagawa M, El-Agnaf OM, Yamada M. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer’s disease. Brain Res. 2009;1251:1–6. https://doi.org/10.1016/j.brainres.2008.11.055.
Galbiati A, Carli G, Hensley M, Ferini-Strambi L. REM Sleep Behavior Disorder and Alzheimer’s Disease: Definitely No Relationship. J Alzheimers Dis. 2018;63(1):1–11. https://doi.org/10.3233/JAD-171164.
Kimura K, Tachibana N, Aso T, Kimura J, Shibasaki H. Subclinical REM sleep behavior disorder in a patient with corticobasal degeneration. Sleep. 1997;20:891–4. 107.
Wetter TC, Brunner H, Collado-Seidel V, Trenkwalder C, Winkelmann J. Sleep and periodic limb movements in corticobasal degeneration. Sleep Med. 2002;3:33–6.
Gatto EM, Uribe Roca C, Martinez O. Subclinical REM sleep behavior disorder (RBD) in two patients with corticobasal degeneration (CBD). Mov Disord. 2005;20(Suppl 10):S107.
Munhoz RP, Teive HA. REM sleep behaviour disorder: how useful is it for the differential diagnosis of parkinsonism? Clin Neurol Neurosurg. 2014;127:71–4. https://doi.org/10.1016/j.clineuro.2014.09.014.
Caparros-Lefebvre D, Elbaz A. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. Lancet. 1999;354(9175):281–6.
Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, Brice A, Tolosa E, Delacourte A, Duyckaerts C. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain. 2002;125(Pt 4):801–11.
Lannuzel A, Hoglinger GU, Verhaeghe S, et al. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Brain. 2007;130(Pt 3):816–27.
Lannuzel A, Michel PP, Höglinger GU, Champy P, Jousset A, Medja F, Lombès A, Darios F, Gleye C, Laurens A, Hocquemiller R, Hirsch EC, Ruberg M. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Neuroscience. 2003;121(2):287–96.
Höglinger GU, Lannuzel A, Khondiker ME, Michel PP, Duyckaerts C, Féger J, Champy P, Prigent A, Medja F, Lombes A, Oertel WH, Ruberg M, Hirsch EC. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem. 2005;95:930–9.
De Cock VC, Lannuzel A, Verhaeghe S, Roze E, Ruberg M, Derenne JP, Willer JC, Vidailhet M, Arnulf I. REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy. Sleep. 2007;30(8):1026–32.
Salva MA, Guilleminault C. Olivopontocerebellar degeneration, abnormal sleep, and REM sleep without atonia. Neurology. 1986;36:576–7.
Wszolek ZK, Pfeiffer RF, Bhatt MH, et al. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Ann Neurol. 1992;32:312–20.
Tsuboi Y, Uitti RJ, Delisle MB, Ferreira JJ, Brefel-Courbon C, Rascol O, Ghetti B, Murrell JR, Hutton M, Baker M, Wszolek ZK. Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family. Arch Neurol. 2002;59:943–50.
Foster N, Wilhelmsen K, Sima A, et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol. 1997;41:706–15.
Reed LA, Schmidt ML, Wszolek ZK, Balin BJ, Soontornniyomkij V, Lee VM, Trojanowski JQ, Schelper RL. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia (“pallido-ponto-nigral degeneration”). J Neuropathol Exp Neurol. 1998;57:588–601.
Boeve BF, Lin SC, Strongosky A, Dickson DW, Wszolek Z. Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred. Arch Neurol. 2006;63:268–72.
Lo Coco D, Cupidi C, Mattaliano A, Baiamonte V, Realmuto S, Cannizzaro E. REM sleep behavior disorder in a patient with frontotemporal dementia. Neurol Sci. 2012;33:371–3. https://doi.org/10.1007/s10072-011-0702-5.
Daoud H, Postuma RB, Bourassa CV, Rochefort D, Gauthier MT, Montplaisir J, Gagnon JF, Arnulf I, Dauvilliers Y, Charley CM, Inoue Y, Sasai T, Högl B, Desautels A, Frauscher B, Cochen De Cock V, Rouleau GA, Dion PA. C9orf72 repeat expansions in rapid eye movement sleep behaviour disorder. Can J Neurol Sci. 2014;41:759–62. https://doi.org/10.1017/cjn.2014.39.
Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chiò A, Restagno G, Nicolaou N, Simon-Sanchez J, van Swieten JC, Abramzon Y, Johnson JO, Sendtner M, Pamphlett R, Orrell RW, Mead S, Sidle KC, Houlden H, Rohrer JD, Morrison KE, Pall H, Talbot K, Ansorge O, Chromosome 9-ALS/FTD Consortium, French research network on FTLD/FTLD/ALS, ITALSGEN Consortium, Hernandez DG, Arepalli S, Sabatelli M, Mora G, Corbo M, Giannini F, Calvo A, Englund E, Borghero G, Floris GL, Remes AM, Laaksovirta H, McCluskey L, Trojanowski JQ, Van Deerlin VM, Schellenberg GD, Nalls MA, Drory VE, Lu CS, Yeh TH, Ishiura H, Takahashi Y, Tsuji S, Le Ber I, Brice A, Drepper C, Williams N, Kirby J, Shaw P, Hardy J, Tienari PJ, Heutink P, Morris HR, Pickering-Brown S, Traynor BJ. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323–30. https://doi.org/10.1016/S1474-4422(12)70043-1.
Claassen DO, Parisi JE, Giannini C, Boeve BF, Dickson DW, Josephs KA. Frontotemporal dementia mimicking dementia with Lewy bodies. Cogn Behav Neurol. 2008;21:157–63.
Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, Ahlskog JE, Caselli RJ, Jacobson S, Sabbagh M, Adler C, Woodruff B, Beach TG, Iranzo A, Gelpi E, Santamaria J, Tolosa E, Singer C, Mash DC, Luca C, Arnulf I, Duyckaerts C, Schenck CH, Mahowald MW, Dauvilliers Y, Graff-Radford NR, Wszolek ZK, Parisi JE, Dugger B, Murray ME, Dickson DW. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013;14:754–62. https://doi.org/10.1016/j.sleep.2012.10.015.
Landolt HP, Glatzel M, Blättler T, Achermann P, Roth C, Mathis J, Weis J, Tobler I, Aguzzi A, Bassetti CL. Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease. Neurology. 2006;66:1418–249.
Kang P, de Bruin GS, Wang LH, Ward BA, Ances BM, Lim MM, Bucelli RC. Sleep pathology in Creutzfeldt-Jakob disease. J Clin Sleep Med. 2016;12:1033–9. https://doi.org/10.5664/jcsm.5944.
The ALS CNTF Treatment Study (ACTS) Phase I–II Study Group. The amyotrophic lateral sclerosis functional rating scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol. 1996;53:141–7.
Marangi G, Traynor BJ. Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res. 2015;1607:75–93. https://doi.org/10.1016/j.brainres.2014.10.009.
Laferriere F, Polymenidou M. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis. Swiss Med Wkly. 2015;145:w14054. https://doi.org/10.4414/smw.2015.14054.
Ferri R, Gagnon JF, Postuma RB, Rundo F, Montplaisir JY. Comparison between an automatic and a visual scoring method of the chin muscle tone during rapid eye movement sleep. Sleep Med. 2014;15:661–5. https://doi.org/10.1016/j.sleep.2013.12.022.
Luppi PH, Clément O, Sapin E, Gervasoni D, Peyron C, Léger L, Salvert D, Fort P. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder. Sleep Med Rev. 2011;15:153–63. https://doi.org/10.1016/j.smrv.2010.08.002.
Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, Guillot-Noël L, Russaouen O, Bruneteau G, Pradat PF, Le Forestier N, Vandenberghe N, Danel-Brunaud V, Guy N, Thauvin-Robinet C, Lacomblez L, Couratier P, Hannequin D, Seilhean D, Le Ber I, Corcia P, Camu W, Brice A, Rouleau G, LeGuern E, Meininger V. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet. 2010;47:554–60. https://doi.org/10.1136/jmg.2010.077180.
Walker FO. Huntington’s disease. Semin Neurol. 2007;27:143–50.
Taylor N, Bramble D. Sleep disturbance and Huntingdon’s disease. Br J Psychiatry. 1997;171:393.
Emser W, Brenner M, Stober T, Schimrigk K. Changes in nocturnal sleep in Huntington’s and Parkinson’s disease. J Neurol. 1988;235:177–9.
Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES. Disintegration of the sleep-wake cycle and circadian timing in Huntington’s disease. J Neurosci. 2005;25:157–63.
Goodman AO, Rogers L, Pilsworth S, McAllister CJ, Shneerson JM, Morton AJ, Barker RA. Asymptomatic sleep abnormalities are a common early feature in patients with Huntington’s disease. Curr Neurol Neurosci Rep. 2011;11:211–7. https://doi.org/10.1007/s11910-010-0163-x.
Neutel D, Tchikviladze M, Charles P, et al. Nocturnal agitation in Huntington disease is caused by arousal-related abnormal movements rather than by rapid eye movement sleep behavior disorder. Sleep Med. 2015;16:754–9. https://doi.org/10.1016/j.sleep.2014.12.021.
Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993;5:344–50.
Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770–88.
Boeve BF. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci. 2010;1184:15–54. https://doi.org/10.1111/j.1749-6632.2009.05115.x.
Scherfler C, Frauscher B, Schocke M, Iranzo A, Gschliesser V, Seppi K, Santamaria J, Tolosa E, Högl B, Poewe W, SINBAR (Sleep Innsbruck Barcelona) Group. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol. 2011;69:400–7. https://doi.org/10.1002/ana.22245.
García-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, Leu-Semenescu S, Gallea C, Quattrocchi G, Pita Lobo P, Poupon C, Benali H, Arnulf I, Vidailhet M, Lehericy S. The coeruleus/subcoeruleus complex in rapid eye movement sleeps behaviour disorders in Parkinson’s disease. Brain. 2013;136:2120–9. https://doi.org/10.1093/brain/awt152.
Svetel M, Mijajlović M, Tomić A, Kresojević N, Pekmezović T, Kostić VS. Transcranial sonography in Wilson’s disease. Parkinsonism Relat Disord. 2012;18:234–8. https://doi.org/10.1016/j.parkreldis.2011.10.007.
Kim H, Yun JY, Choi KG, Koo H, Han HJ. Sleep related Problems as Nonmotor Symptom of Dentatorubropallidoluysian Atrophy. J Korean Med Sci. 2018;11:33(17):e130. https://doi.org/10.3346/jkms.2018.33.e130.
Li X, James S, Lei PJ. Interactions between α-synuclein and tau protein: implications to neurodegenerative disorders. Mol Neurosci. 2016;60:298–304. https://doi.org/10.1007/s12031-016-0829-1.
Lei P, Ayton S, Finkelstein DI, Adlard PA, Masters CL, Bush AI. Tau protein: relevance to Parkinson’s disease. Int J Biochem Cell Biol. 2010;42(11):1775–8. https://doi.org/10.1016/j.biocel.2010.07.016.
Coakeley S, Strafella AP. Imaging tau pathology in Parkinsonisms. NPJ Parkinsons Dis. 2017;3:22. https://doi.org/10.1038/s41531-017-0023-3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ferini-Strambi, L., Casoni, F.M., Zucconi, M. (2019). RBD and Non-synuclein Neurodegenerative Disorders: A Critical Appraisal. In: Schenck, C., Högl, B., Videnovic, A. (eds) Rapid-Eye-Movement Sleep Behavior Disorder. Springer, Cham. https://doi.org/10.1007/978-3-319-90152-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-90152-7_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90151-0
Online ISBN: 978-3-319-90152-7
eBook Packages: MedicineMedicine (R0)